Skip to main content

Terns Pharmaceuticals, Inc.

TERNDelisted May 5, 2026
Industry
Pharmaceutical Preparations
SEC CIK
0001831363

Terns Pharmaceuticals, Inc. was delisted on May 5, 2026; its insiders filed their last Form 4 on May 5, 2026; 317 institutions reported holding it in 13F filings for Q1 2026, worth $6.56B in total; Soros Fund Management was the only superinvestor holding it.

13F holders, Q2 2024

Institutional positions in Terns Pharmaceuticals, Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
126
+15 vs. Q1 2024
Shares held
65.6M
+2.38M (+3.8%) vs. Q1 2024
Total value
$446.7M
+$32.1M (+7.7%) vs. Q1 2024
New holders
40
45 more added
Sold out
25
24 more reduced

1 institution that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q1 2024: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting TERN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2024: 126 institutions
Q1 2021: 42 institutionsQ2 2021: 36 institutionsQ3 2021: 34 institutionsQ4 2021: 37 institutionsQ1 2022: 44 institutionsQ2 2022: 42 institutionsQ3 2022: 45 institutionsQ4 2022: 65 institutionsQ1 2023: 79 institutionsQ2 2023: 103 institutionsQ3 2023: 93 institutionsQ4 2023: 103 institutionsQ1 2024: 112 institutionsQ2 2024: 126 institutionsQ3 2024: 156 institutionsQ4 2024: 157 institutionsQ1 2025: 138 institutionsQ2 2025: 130 institutionsQ3 2025: 141 institutionsQ4 2025: 248 institutionsQ1 2026: 317 institutionsQ2 2026: 1 institution
Value heldQ2 2024: $446.7M
Q1 2021: $393.7MQ2 2021: $203.8MQ3 2021: $174.3MQ4 2021: $116.7MQ1 2022: $50.0MQ2 2022: $36.5MQ3 2022: $178.1MQ4 2022: $506.2MQ1 2023: $630.2MQ2 2023: $505.0MQ3 2023: $310.4MQ4 2023: $412.7MQ1 2024: $414.8MQ2 2024: $446.7MQ3 2024: $663.1MQ4 2024: $477.2MQ1 2025: $229.4MQ2 2025: $310.0MQ3 2025: $665.7MQ4 2025: $4.95BQ1 2026: $6.56BQ2 2026: $75.4K
Institutions holding TERN and their total value by quarter
QuarterHoldersValue
Q2 20261$75.4K
Q1 2026317$6.56B
Q4 2025248$4.95B
Q3 2025141$665.7M
Q2 2025130$310.0M
Q1 2025138$229.4M
Q4 2024157$477.2M
Q3 2024156$663.1M
Q2 2024126$446.7M
Q1 2024112$414.8M
Q4 2023103$412.7M
Q3 202393$310.4M
Q2 2023103$505.0M
Q1 202379$630.2M
Q4 202265$506.2M
Q3 202245$178.1M
Q2 202242$36.5M
Q1 202244$50.0M
Q4 202137$116.7M
Q3 202134$174.3M
Q2 202136$203.8M
Q1 202142$393.7M

Institutions, Q2 2024

Shares, value and share of portfolio for each institution holding Terns Pharmaceuticals, Inc.; share changes are against Q1 2024.

Institutions holding TERN in Q2 2024
InstitutionSharesValue% of portfolioChange in sharesAction
Ikarian Capital, LLC458,497$3.12M0.97%+370,000+418.1%Added
Russell Investments Group, Ltd.648,116$4.41M0.01%+15,151+2.4%Added
Goldman Sachs Group Inc698,714$4.76M0.00%+491,728+237.6%Added
Woodline Partners LP745,044$5.07M0.05%+745,044New
Nuveen Asset Management, LLC747,442$5.09M0.00%+587,870+368.4%Added
Fairmount Funds Management LLC748,996$5.10M0.58%−1,291,004−63.3%Reduced
Superstring Capital Management LP956,542$6.51M8.21%+956,542New
Adage Capital Partners GP, L.L.C.975,000$6.64M0.01%+125,000+14.7%Added
Driehaus Capital Management LLC1,083,905$7.38M0.07%00.0%Unchanged
Geode Capital Management, LLC1,121,862$7.64M0.00%+255,941+29.6%Added
Franklin Resources Inc1,122,842$7.65M0.00%−1,259,054−52.9%Reduced
Millennium Management LLC1,140,392$7.77M0.01%−2,292,400−66.8%Reduced
Great Point Partners LLC1,149,406$7.83M1.50%−160,569−12.3%Reduced
State Street Corp1,176,833$8.01M0.00%+271,339+30.0%Added
Octagon Capital Advisors LP1,364,400$9.29M1.53%+739,400+118.3%Added
Citadel Advisors LLC1,459,950$9.94M0.01%−1,505,636−50.8%Reduced
Schonfeld Strategic Advisors LLC2,268,428$15.4M0.12%+1,072,634+89.7%Added
Vanguard Group Inc2,300,942$15.7M0.00%+101,936+4.6%Added
Point72 Asset Management, L.P.2,690,376$18.3M0.06%+469,176+21.1%Added
FMR LLC2,767,096$18.8M0.00%+4,970+0.2%Added
VR Adviser, LLC3,410,058$23.2M1.48%00.0%Unchanged
BlackRock Inc.4,120,508$28.1M0.00%+804,979+24.3%Added
Soleus Capital Management, L.P.4,947,738$33.7M2.97%+4,947,738New
Deep Track Capital, LP6,100,000$41.5M1.24%00.0%Unchanged
Vivo Capital, LLC6,182,992$42.1M3.89%−475,000−7.1%Reduced
OrbiMed Advisors LLC7,619,135$51.9M1.11%00.0%Unchanged
Janus Henderson Group PLC0$00.00%−2,003,263−100.0%Sold out
Suvretta Capital Management, LLC0$00.00%−1,363,675−100.0%Sold out
Affinity Asset Advisors, LLC0$00.00%−450,000−100.0%Sold out
Monashee Investment Management LLC0$00.00%−300,000−100.0%Sold out
Silverarc Capital Management, LLC0$00.00%−250,551−100.0%Sold out
Exome Asset Management LLC0$00.00%−227,821−100.0%Sold out
Norges Bank0$00.00%−137,100−100.0%Sold out
HRT Financial LP0$00.00%−74,755−100.0%Sold out
Squarepoint Ops LLC0$00.00%−71,361−100.0%Sold out
Swiss National Bank0$00.00%−61,000−100.0%Sold out
ExodusPoint Capital Management, LP0$00.00%−54,722−100.0%Sold out
Atom Investors LP0$00.00%−50,825−100.0%Sold out
Deerfield Management Company, L.P. (Series C)0$00.00%−24,060−100.0%Sold out
American International Group, Inc.0$00.00%−21,370−100.0%Sold out
Dynamic Technology Lab Private Ltd0$00.00%−21,206−100.0%Sold out
UBS Asset Management Americas Inc0$00.00%−17,870−100.0%Sold out
Kennedy Capital Management, Inc.0$00.00%−15,466−100.0%Sold out
ProShare Advisors LLC0$00.00%−12,121−100.0%Sold out
Zurcher Kantonalbank (Zurich Cantonalbank)0$00.00%−7,782−100.0%Sold out
Metropolitan Life Insurance Co0$00.00%−2,395−100.0%Sold out
Quadrant Capital Group LLC0$00.00%−1,814−100.0%Sold out
Aquatic Capital Management LLC0$00.00%−1,400−100.0%Sold out
Cubist Systematic Strategies, LLC0$00.00%−327−100.0%Sold out
The PNC Financial Services Group, Inc.0$00.00%−17−100.0%Sold out
Nelson, Van Denburg & Campbell Wealth Management Group, LLC0$00.00%−9−100.0%Sold out
Credit Suisse AG––––Not filed